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Informed consent for psychotherapy includes
much more than the setting
Trachsel Manuel, Biller-Andorno Nikola
Institute of Biomedical Ethics and History of Medicine, University of Zurich, Switzerland
In a recent article on informed consent (IC) in The Lancet
Psychiatry, we pointed out that whereas “[i]n most fields of
health care, obtaining the patient’s IC for treatment is con-
sidered a moral duty, reflecting both the individual’s right
to self-determination and the principle of patient protection
[…], [i]n psychotherapy, IC is not only a moral duty but
also has obvious benefits for patients and therapists” [1].
Nevertheless, informed consent for psychotherapy is still
not routine [2].
Novosel argues in his viewpoint article in Swiss Medical
Weekly that IC “has been a crucial element in psychother-
apy since its beginnings, but under another name: the set-
ting” [3]. We agree that defining the setting – for example,
providing basic information on time, place, duration, fre-
quency, or fees – is an important element of IC for a psy-
chotherapeutic intervention. However, informing patients
about the setting should not be confused with the challeng-
ing task of IC. This is where we see the major flaw with
Novosel’s argument. In addition, it remains unclear, what
“the setting” specifically entails, and the references cited in
the comment do not help to clarify this point [4].
Reliable IC includes the communication of the patient’s
diagnosis and prognosis, discussion of potential benefits,
as well as risks and harms, of psychotherapy [e.g., 5];
it comprises agreement about the goals and tasks of the
psychotherapy that may support treatment success [6]; it
should include information about the evidence base of the
provided psychotherapeutic method [7] and possible alter-
native treatments, including other psychotherapeutic ap-
proaches and pharmacotherapy. In summary, IC “proce-
dures emphasize the patient’s role in making treatment
decisions, increasing a sense of ownership over the
process” [8].
There are only a few empirical studies on the practice of
IC in psychotherapy. One qualitative study in Austria has
found that psychotherapists seem to provide basic informa-
tion about the setting (e.g., duration or financial aspects)
much more reliably than the more demanding requirements
such as the evidence base of the provided psychothera-
peutic method, or possible alternative treatments [2]. This
finding corresponds with our own experience. We there-
fore call for the topic of how to provide valid and reliable
IC to become an integral constituent of psychotherapy
training programs and continuing education – along with
other ethical and legal issues of psychotherapy.
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